Boehringer Ingelheim Jobs

Job Information

Boehringer Ingelheim Post Doctoral Fellow - Molecular Pathology in RIDGEFIELD, Connecticut

Boehringer Ingelheim is an equal opportunity global employer who takes pride in maintaining a diverse and inclusive culture. We embrace diversity of perspectives and strive for an inclusive environment which benefits our employees, patients and communities.


The Experimental Pathology group within Non-clinical Drug Safety (NDS) for Development at Boehringer Ingelheim is seeking a talented and motivated Post-Doctoral Fellow to join their team at the Ridgefield, CT, site. This scientist will advance our understanding of oncolytic viruses (OVs) and non-clinical models used to predict their toxicity. The candidate will be expected to develop and publish research findings to both internal and external scientific communities and to collaborate broadly with colleagues in the Integrative Toxicology, PK/PD, Translational Medicine, and Cancer Immunotherapy groups.

As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development, and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the success of the company. We realize that our strength and competitive advantage lie with our people. We support our employees in a number of ways to foster a healthy working environment, meaningful work, diversity and inclusion, mobility, networking, and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees.

Postdoctoral Research Areas of Focus:

  • Develop and apply state-of-the-art methods in molecular pathology

  • Characterize cellular responses to OV therapies in normal and cancer tissues

  • Investigate immunologic determinants of OV replication and immunogenicity

  • Deepen mechanistic understanding of potential OV toxicities

  • Evaluate novel translatable safety biomarkers for OV therapies

Desired Experience, Skills, and Abilities:

  • Recently granted or anticipated PhD degree in Cancer Biology, Tumor Immunology, or Virology or related area

  • Demonstrated knowledge of tissue-based biomarkers, mouse tumor models, and image analysis

  • Experience with pathology, immunohistochemistry, and in situ hybridization methods a plus

  • Ability to collaborate with scientists from other areas

  • Exceptional written and oral communication skills

Eligibility Requirements :

  • Must be legally authorized to work in the United States without restriction.

  • Must be willing to take a drug test and post-offer physical (if required)

  • Must be 18 years of age or older

Who We Are :

At Boehringer Ingelheim we create value through innovation with one clear goal: to improve the lives of patients. We develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company we focus on long term performance. We are powered by 50.000 employees globally who nurture a diverse, collaborative and inclusive culture. Learning and development for all employees is key because your growth is our growth.

Want to learn more? Visit at and join us in our effort to make more health. Boehringer Ingelheim, including Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA, Boehringer Ingelheim Animal Health USA, Inc., Merial Barceloneta, LLC and Boehringer Ingelheim Fremont, Inc. is an equal opportunity and affirmative action employer committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender identity or expression; affectional or sexual orientation; disability; veteran or military status, including protected veteran status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law


Organization: US-BI Pharma/BI USA

Title: Post Doctoral Fellow - Molecular Pathology

Location: Americas-US-CT-Ridgefield

Requisition ID: 2013754